Fulgent Genetics (FLGT) Short term Debt (2020 - 2025)
Historic Short term Debt for Fulgent Genetics (FLGT) over the last 6 years, with Q3 2025 value amounting to $28.5 million.
- Fulgent Genetics' Short term Debt rose 593.06% to $28.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.5 million, marking a year-over-year increase of 593.06%. This contributed to the annual value of $27.6 million for FY2024, which is 2163.0% up from last year.
- According to the latest figures from Q3 2025, Fulgent Genetics' Short term Debt is $28.5 million, which was up 593.06% from $27.6 million recorded in Q2 2025.
- Over the past 5 years, Fulgent Genetics' Short term Debt peaked at $45.3 million during Q2 2021, and registered a low of $14.5 million during Q2 2023.
- Over the past 5 years, Fulgent Genetics' median Short term Debt value was $26.3 million (recorded in 2024), while the average stood at $25.0 million.
- In the last 5 years, Fulgent Genetics' Short term Debt crashed by 5006.73% in 2023 and then skyrocketed by 8186.03% in 2024.
- Over the past 5 years, Fulgent Genetics' Short term Debt (Quarter) stood at $19.8 million in 2021, then fell by 24.27% to $15.0 million in 2022, then skyrocketed by 51.34% to $22.7 million in 2023, then increased by 21.63% to $27.6 million in 2024, then increased by 3.38% to $28.5 million in 2025.
- Its Short term Debt was $28.5 million in Q3 2025, compared to $27.6 million in Q2 2025 and $27.7 million in Q1 2025.